About PredxBio
PredxBio is a precision healthcare technology company that provides tissue intelligence solutions for pharmaceutical drug development. The company's flagship SpaceIQ platform transforms complex spatial and multi-omic tissue data into explainable, decision-ready insights that guide drug development from early discovery through clinical programs and portfolio strategy. By resolving functional cell states, spatial microenvironments, and cell-cell interactions, PredxBio uncovers response-driving biology that conventional analyses miss. The platform integrates unbiased spatial analytics with explainable AI to systematically characterize tissue organization, functional states, and molecular interactions across spatial imaging and multi-omic data. SpaceIQ supports three key stages of drug development: Discovery & Mechanism Intelligence to reveal response-defining tissue biology for target selection; Translational & Clinical Readiness to define predictive tissue-based biomarkers and stratify patient populations; and Trial & Program-Scale Decision Support to guide trial strategy and enable reproducible tissue intelligence across studies. The company serves pharmaceutical companies, biotech firms, and drug developers, helping teams move from exploratory tissue analysis to confident, development-ready decisions. PredxBio's approach enables earlier go/no-go decisions, stronger biomarker strategies, patient stratification based on tissue-level biology, and more efficient clinical development programs.
Clinical Focus
Medical conditions and clinical areas addressed by PredxBio.
Who It Serves
Milestones & Awards
Recent Milestones
Hosted Spatial Intelligence Summit in Pittsburgh (November 2025). Presenting 6 posters at AACR 2026 conference (April 17-22, 2026, San Diego). Released white paper on Spatially Intelligent Platform.
Company Details
- Headquarters
- Pittsburgh, PA, USA
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.